Leatt (LEAT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Sep, 2026Executive summary
The annual meeting will be held virtually on November 20, 2026, with voting available online, by phone, or by mail.
Shareholders as of September 24, 2026, are eligible to vote on key proposals, including director elections and compensation matters.
The Board unanimously recommends approval of all proposals, including the new equity incentive plan and auditor ratification.
Proxy materials and the 2025 Annual Report are available online, with printed copies upon request.
Voting matters and shareholder proposals
Proposals include electing three directors, ratifying M&K CPAS, PLLC as auditor, approving the 2026 Equity Incentive Plan, a say-on-pay vote, and setting the frequency of future say-on-pay votes.
The Board recommends voting for all director nominees, for all proposals, and for a three-year frequency on executive compensation votes.
Shareholders may submit proposals for the 2027 meeting by October 8, 2026.
Board of directors and corporate governance
The Board consists of three members: Dr. Christopher Leatt (Chairman), Sean Macdonald (CEO/President/CFO), and Jeffrey Guzy (Director).
The Board has Audit and Compensation Committees, both chaired by independent director Jeffrey Guzy.
The Board separates the roles of Chair and CEO and emphasizes diversity, integrity, and effective risk oversight.
All directors attended at least 75% of meetings in 2025.
Latest events from Leatt
- Revenues up 14% and net income up 19% for H1 2026, with strong direct sales growth.LEAT
Q2 2026 - Q1 2026 revenue up 27%, net income up 58%, with strong global demand and stable margins.LEAT
Q1 2026 - 41% revenue growth and 248% net income increase highlight robust 2025 performance.LEAT
Q4 2025 - Annual meeting to elect directors and ratify auditors, with focus on governance and transparency.LEAT
Proxy Filing - Annual meeting set for July 1, 2025, to elect directors and ratify the auditor.LEAT
Proxy Filing - Q3 2024 saw modest revenue growth and margin gains, but net income fell sharply.LEAT
Q3 2024 - Q2 revenue fell 18% as distributor sales lagged, but direct channels and liquidity improved.LEAT
Q2 2024 - Directors and auditors were approved by strong majorities, with no shareholder questions.LEAT
AGM 2024 - Q4 revenue up 14% and margins improved, but full-year sales and profit declined.LEAT
Q4 2024